Literature DB >> 2960448

Requirements for the stimulation of allogeneic T lymphocytes by acute non-lymphoblastic leukaemia cells.

L K Ashman1, G W Kriek, S J Cooper, D E O'Keefe.   

Abstract

Blast cell populations from 32 patients with acute non-lymphoblastic leukaemia of various morphological types have been examined for their ability to stimulate allogeneic T lymphocytes from normal donors in one-way mixed leucocyte culture (MLC). At the same time, these leukaemic cell populations were examined for the amounts of major histocompatibility complex Class I and Class II antigens they expressed, and their ability to release interleukin 1 (IL1) in culture both with and without stimulation by lipopolysaccharide. The abilities of the leukaemic cell populations to stimulate in MLC, and to produce IL1, were found to be associated with the expression of morphological characteristics of monocytic differentiation, and correlated significantly. In contrast, no correlation was observed between the extent of Class I or Class II expression and MLC stimulatory ability. Many myeloblast populations of immature phenotype were unable to stimulate allogeneic T cells despite their strong expression of these antigens. This lack of stimulatory ability was not overcome by the addition of exogenous IL1. We therefore conclude that the correlation between the production of IL1 and MLC stimulatory ability does not necessarily imply a cause/effect relationship, and that the interaction between allo-antigen and the T cell receptor together with a supply of lymphokine 'co-stimulator' is not sufficient to activate resting T lymphocytes. The failure of some Class I and II antigen positive leukaemic blasts to stimulate in MLC even in the presence of exogenous IL1 may be due to the lack of other differentiation-associated cell surface molecules necessary for stable cell-cell interaction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960448     DOI: 10.1007/bf00199155

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  36 in total

Review 1.  Properties and usefulness of the original K-562 human myelogenous leukemia cell line.

Authors:  B B Lozzio; C B Lozzio
Journal:  Leuk Res       Date:  1979       Impact factor: 3.156

2.  Preparation and characterization of lymphocyte-activating factor (LAF) from acute monocytic and myelomonocytic leukemia cells.

Authors:  L B Lachman; J O Moore; R S Metzgar
Journal:  Cell Immunol       Date:  1978-11       Impact factor: 4.868

3.  Enhancement of DNA synthesis and cAMP content of mouse thymocytes by mediator(s) derived from adherent cells.

Authors:  J J Oppenheim; A Shneyour; A I Kook
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

Review 4.  The immunogenicity of tumour cells.

Authors:  L K Ashman
Journal:  Immunol Cell Biol       Date:  1987-08       Impact factor: 5.126

5.  An HLA-DR negative acute leukaemia which stimulates MLC and CMC responses.

Authors:  G M Taylor; W Fergusson; P A Dyer; R Harris; G Morrell
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

6.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

7.  Proliferative response of normal and activated human lymphocytes to tetradecanoyl phorbol acetate.

Authors:  L K Ashman
Journal:  Cell Immunol       Date:  1984-09       Impact factor: 4.868

8.  Surface Ia-like expression and MLR-stimulating capacity of human leukemic myeloblasts: implications for immunotherapy and prognosis.

Authors:  T D Miale; L A Stenke; J B Lindblom; A M Sjögren; P G Reizenstein; A M Udén; D L Lawson
Journal:  Acta Haematol       Date:  1982       Impact factor: 2.195

9.  Autologous responses to human leukaemic cells in mixed leucocyte culture.

Authors:  L K Ashman; D E O'Keefe; C A Juttner; I R Toogood; M S Rice
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

10.  Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.

Authors:  S Gillis; J Watson
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  1 in total

1.  HL-60 myeloid leukaemia cells acquire immunostimulatory capability upon treatment with retinoic acid: analysis of the responding population and mechanism of cytotoxic lymphocyte activation.

Authors:  S M Geary; L K Ashman
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.